VolitionRx Ltd
VNRX
46 hedge funds and large institutions have $21.3M invested in VolitionRx Ltd in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 21 reducing their positions, and 22 closing their positions.
0.21% less ownership
Funds ownership: 0.82% → 0.61% (-0.21%)
19% less funds holding
Funds holding: 57 → 46 (-11)
35% less capital invested
Capital invested by funds: $32.9M → $21.3M (-$11.6M)
50% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 22
71% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 21
94% less call options, than puts
Call options by funds: $17K | Put options by funds: $273K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$870K |
| 2 |
Renaissance Technologies
New York
|
+$733K |
| 3 |
E
Ergoteles
New York
|
+$457K |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$288K |
| 5 |
HF
HRT Financial
New York
|
+$212K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.65M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.09M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$818K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$784K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$634K |
VNRX Hedge Fund Activity: Q2 2021 in Review
46 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2021, worth a combined $21.3M — down 35% from $32.9M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of VNRX and 11 opened new positions — a net loss of 11 holders — while 21 trimmed existing stakes and 6 added.
The largest buyer was Millennium Management, adding an estimated $870K. The largest seller was BlackRock, cutting an estimated $4.65M.
- 46 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2021, down from 57 in Q1 2021.
- Funds reported $21.3M of VolitionRx Ltd stock for Q2 2021, down 35% quarter-over-quarter.
- 11 funds opened new VolitionRx Ltd positions in Q2 2021 and 22 closed out, a net change of -11 holders.
- The largest VolitionRx Ltd buyer in Q2 2021 was Millennium Management, an estimated $870K added.
- The largest VolitionRx Ltd seller in Q2 2021 was BlackRock, an estimated $4.65M sold.
Based on aggregated 13F filings for Q2 2021.